Shanghai No.1 Pharmacy (600833.SH) issues a forecast report, estimating that the net profit for the year 2024 will be between 1.24 billion and 1.85 billion yuan, an increase of 38.90% to 107.22% compared to the previous year.

Shanghai No.1 Pharmacy (600833.SH) announced that the company expects to achieve a net profit attributable to the owners of the parent company of 124 million yuan to 185 million yuan in 2024. Compared with the same period last year, it will increase by 34.72 million yuan to 95.72 million yuan, a year-on-year increase of 38.90% to 107.22%.